Literature DB >> 16145169

Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.

Wonkeun Song1, Ellen S Moland, Nancy D Hanson, James S Lewis, James H Jorgensen, Kenneth S Thomson.   

Abstract

A case of failure of cefepime treatment of a bloodstream infection with AmpC-producing Klebsiella pneumoniae is reported. The failure was attributed to extended-spectrum beta-lactamase (ESBL) acquisition by the isolate, possibly during therapy. Problems encountered with ESBL detection in AmpC-producing isolates are discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145169      PMCID： PMC1234124          DOI： 10.1128/JCM.43.9.4891-4894.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals.

Authors:  Ellen Smith Moland; Jennifer A Black; Jason Ourada; Mark D Reisbig; Nancy D Hanson; Kenneth S Thomson
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 4.  AmpC beta-lactamases: what do we need to know for the future?

Authors:  Nancy D Hanson
Journal:  J Antimicrob Chemother       Date:  2003-05-29       Impact factor: 5.790

5.  AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.

Authors:  Jennifer A Black; Ellen Smith Moland; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

6.  Characterization of beta-lactamases in situ on polyacrylamide gels.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 7.  Klebsiella pulmonary infections: occurrence at one medical center and review.

Authors:  J L Carpenter
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

8.  Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Authors:  C Brun-Buisson; P Legrand; A Philippon; F Montravers; M Ansquer; J Duval
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

9.  Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.

Authors:  M Alvarez; J H Tran; N Chow; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 10.  Controversies about extended-spectrum and AmpC beta-lactamases.

Authors:  K S Thomson
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883
View more
  19 in total

1.  First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test.

Authors:  Etienne Ruppé; Philippe Bidet; Charlotte Verdet; Guillaume Arlet; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

2.  Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae.

Authors:  Ling-Xiang Zhu; Zhi-Wei Zhang; Dong Liang; Di Jiang; Can Wang; Ning Du; Qiong Zhang; Keith Mitchelson; Jing Cheng
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

3.  Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae.

Authors:  M Parta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-13       Impact factor: 3.267

4.  Ertapenem pharmacokinetics and pharmacodynamics during continuous ambulatory peritoneal dialysis.

Authors:  Katie E Cardone; Darren W Grabe; Robert W Kulawy; Rachid Daoui; Joseph Roglieri; Shari Meola; George L Drusano; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

5.  Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes.

Authors:  Dirk M Leinberger; Verena Grimm; Maya Rubtsova; Jan Weile; Klaus Schröppel; Thomas A Wichelhaus; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

6.  Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection.

Authors:  Peter J Petersen; C Hal Jones; Aranapakam M Venkatesan; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

7.  Prevalence of plasmid-mediated AmpC β-lactamases in Escherichia coli and Klebsiella pneumonia at tertiary care hospital of Islamabad, Pakistan.

Authors:  Muhammad Shafiq; Hazir Rahman; Muhammad Qasim; Najma Ayub; Shagufta Hussain; Jafar Khan; Madiha Naeem
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

8.  Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.

Authors:  Trent G Towne; James S Lewis; Monica Herrera; Brian Wickes; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

9.  Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.

Authors:  Mario Tumbarello; Michela Sali; Enrico Maria Trecarichi; Fiammetta Leone; Marianna Rossi; Barbara Fiori; Gennaro De Pascale; Tiziana D'Inzeo; Maurizio Sanguinetti; Giovanni Fadda; Roberto Cauda; Teresa Spanu
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

10.  Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results.

Authors:  Fred C Tenover; Shannon L Emery; Carol A Spiegel; Patricia A Bradford; Samantha Eells; Andrea Endimiani; Robert A Bonomo; John E McGowan
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.